Abstract
131I-Apamistamab-Led Allogeneic Hematopoietic Cell Transplant for Patients with TP53 Mutated R/R AML Results in Significantly Improved Outcomes
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have